SUPRAX

This brand name is authorized in United States. It is also authorized in Canada, Ireland, Turkey, UK.

Active ingredients

The drug SUPRAX contains one active pharmaceutical ingredient (API):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUPRAX Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00868965, 00868981
GB	Medicines & Healthcare Products Regulatory Agency	15762
IE	Health Products Regulatory Authority	47544
TR	İlaç ve Tıbbi Cihaz Kurumu	8699586070037, 8699586070044, 8699586090110, 8699586092107, 8699586280108, 8699586280115
US	FDA, National Drug Code	27437-201, 27437-203, 27437-205, 27437-206, 27437-207, 27437-208, 54348-797, 68180-202, 70934-079